Rubius Therapeutics

Rubius Therapeutics is a clinical-stage biopharmaceutical company developing a new class of medicines called Red Cell Therapeutics™. The company’s proprietary RED PLATFORM® is designed to genetically engineer and culture red cell therapeutics, which are selective, potent, and off-the-shelf allogeneic cellular therapies with the potential to treat multiple diseases across several therapeutic areas.